| Natural killer cells stimulated with PM21 particles expand and biodistribute in vivo: clinical implications for cancer treatment JL Oyer, V Pandey, RY Igarashi, SS Somanchi, A Zakari, M Solh, DA Lee, ... Cytotherapy 18 (5), 653-663, 2016 | 88 | 2016 |
| Difluoromethylornithine combined with a polyamine transport inhibitor is effective against gemcitabine resistant pancreatic cancer SB Gitto, V Pandey, JL Oyer, AJ Copik, FC Hogan, O Phanstiel IV, ... Molecular pharmaceutics 15 (2), 369-376, 2018 | 44 | 2018 |
| CXCL10/CXCR3 signaling contributes to an inflammatory microenvironment and its blockade enhances progression of murine pancreatic precancerous lesions V Pandey, A Fleming-Martinez, L Bastea, HR Doeppler, J Eisenhauer, ... Elife 10, e60646, 2021 | 40 | 2021 |
| Constitutively active Akt1 cooperates with KRasG12D to accelerate in vivo pancreatic tumor onset and progression TM Albury, V Pandey, SB Gitto, L Dominguez, LP Spinel, J Talarchek, ... Neoplasia 17 (2), 175-182, 2015 | 38 | 2015 |
| Targeting the tumor microenvironment in pancreatic ductal adenocarcinoma V Pandey, P Storz Expert review of anticancer therapy 19 (6), 473-482, 2019 | 30 | 2019 |
| Pomalidomide Alters Pancreatic Macrophage Populations to Generate an Immune-Responsive Environment at Precancerous and Cancerous Lesions LI Bastea, GY Liou, V Pandey, AK Fleming, CA Von Roemeling, ... Cancer research 79 (7), 1535-1548, 2019 | 27 | 2019 |
| Synthesis and biological evaluation of antimetastatic agents predicated upon dihydromotuporamine C and its carbocyclic derivatives A Muth, V Pandey, N Kaur, M Wason, C Baker, X Han, TR Johnson, ... Journal of medicinal chemistry 57 (10), 4023-4034, 2014 | 25 | 2014 |
| Anti-ovarian tumor response of donor peripheral blood mononuclear cells is due to infiltrating cytotoxic NK cells V Pandey, JL Oyer, RY Igarashi, SB Gitto, AJ Copik, DA Altomare Oncotarget 7 (6), 7318, 2016 | 23 | 2016 |
| Differential expression of polyamine pathways in human pancreatic tumor progression and effects of polyamine blockade on tumor microenvironment SP Nakkina, SB Gitto, V Pandey, JG Parikh, D Geerts, HC Maurer, ... Cancers 13 (24), 6391, 2021 | 22 | 2021 |
| The discovery of indolone GW5074 during a comprehensive search for non-polyamine-based polyamine transport inhibitors PO Dobrovolskaite A, Madan M, Pandey V, Altomare DA International Journal of Biochemistry and Cell Biology, 2021 | 10 | 2021 |
| Prediabetes linked to excess glucagon in transgenic mice with pancreatic active AKT1 TM Albury-Warren, V Pandey, LP Spinel, MM Masternak, DA Altomare J Endocrinol 228 (1), 49-59, 2016 | 9 | 2016 |
| Dfmo improves survival and increases immune cell infiltration in association with myc downregulation in the pancreatic tumor microenvironment SP Nakkina, SB Gitto, JM Beardsley, V Pandey, MW Rohr, JG Parikh, ... International journal of molecular sciences 22 (24), 13175, 2021 | 4 | 2021 |
| Signaling via a CD28/CD40 chimeric costimulatory antigen receptor (CoStAR™), targeting folate receptor alpha, enhances T cell activity and augments tumor reactivity of tumor … M Kalaitsidou, OR Moon, M Sykorova, L Bao, Y Qu, S Sukumaran, ... Frontiers in Immunology 14, 1256491, 2023 | 2 | 2023 |
| A CD45RO+ stem cell memory T cell population intermediate to canonical stem cell memory and central memory T cells in human cancer. D Powell Jr, M Eiva, E Brown, V Pandey, A Benton, S Thomas, W Meng, ... | 1 | 2022 |
| INCA33890, a novel PD-1× TGFꞵR2 bispecific antibody conditionally antagonizes TGFꞵ signaling in primary immune cells co-expressing PD-1 LCS Wang, R Klooster, A Kulkarni, AG de Vinuesa, M Soloviev, ... Cancer Research 83 (7_Supplement), 2936-2936, 2023 | | 2023 |
| 1024 Illuminating stem memory T cell (Tscm) heterogeneity in human cancer: characterization of a unique CD45RO+ Tscm population in human ovarian cancer E Brown, M Eiva, V Pandey, A Benton, S Thomas, W Meng, A Rosenfeld, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
| 885 Enhancing immune checkpoint inhibitor efficacy with anti-angiogenics in ovarian cancer S Gitto, S Medvedev, V Pandey, D Omran, M Anderson, L Schwartz, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
| Differential polyamine expression in human pancreatic cancer supports the use of polyamine blockade therapy to modulate the in vivo pancreatic tumor … SP Nakkina, SB Gitto, V Pandey, J Parikh, D Geerts, C Maurer, KP Olive, ... Cancer Research 82 (12_Supplement), 235-235, 2022 | | 2022 |
| DFMO based improvement in survival of pancreatic cancer-bearing mice is associated with modulation of immune suppression in the tumor microenvironment SP Nakkina, SB Gitto, JM Beardsley, V Pandey, MM Rohr, J Parikh, ... Cancer Research 82 (12_Supplement), 3546-3546, 2022 | | 2022 |
| Drug Targeting and Treatment Response of the Microenvironment SP Nakkina, SB Gitto, V Pandey, J Parikh, D Geerts, C Maurer, KP Olive, ... | | 2022 |
Deborah AltomareUniversity of Central FloridaVerified email at ucf.edu
